2026 Global: Home Infusion Therapy Devices Market -Competitive Review (2032) report
Description
The 2026 Global: Home Infusion Therapy Devices Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Ten companies stand out in the Home Infusion Therapy Devices Market, reflecting the global scale and diversity of infusion technologies. B. Braun Melsungen AG, headquartered in Melsungen, Germany, is renowned for its Perfusor and Infusomat infusion pumps, elastomeric devices, and compatible disposables enabling safe, home administration of medications. Fresenius Kabi, based in Bad Homburg vor der Höhe, Germany, complements hospital programs with home-use infusion systems and supportive drug delivery solutions spanning elastomeric pumps, tubing sets, and infusion devices and services. ICU Medical, headquartered in San Clemente, USA, specializes in insulin and analgesia pumps and ancillary products, delivering portable, patient-centric devices for chronic therapy at home. Baxter International, headquartered in Deerfield, USA, leverages a portfolio of infusion systems, resins, and specialty drugs to support home infusion programs. Becton, Dickinson and Company, based in Franklin Lakes, USA, contributes precision infusion pumps, administration sets, and safety-engineered components used in ambulatory and home settings.
Medtronic plc, headquartered in Dublin, Ireland, extends home infusion therapy through its MiniMed insulin pumps, infusion sets, and digital diabetes management platform, enabling remote monitoring and data-informed therapy. Terumo Corporation, based in Tokyo, Japan, markets compact infusion pumps and compatible sets designed for home care, enabling seamless hospital-to-home transitions and safe outpatient administration. Nipro Corporation, headquartered in Osaka, Japan, supplies elastomeric pumps, infusion sets, and IV administration components distributed globally to support ambulatory therapies and home-based regimens. Smiths Medical, headquartered in London, United Kingdom, offers elastomeric and electronic infusion pumps, plus safety-enhanced administration sets used extensively in home infusion programs. AngioDynamics, headquartered in Latham, United States, emphasizes vascular access devices, catheters, and adjunct infusion therapies that support outpatient and home-based infusion pathways. Together, these ten firms shape the market's technological diversity, regulatory compliance, and patient-facing design, driving adoption of home-based chronic therapy and reducing hospital stays across emerging markets globally.
Together, these ten firms shape the competitive landscape of home infusion therapy by combining device ingenuity with manufacturing and distribution networks that reach clinics, home health agencies, and direct-to-patient channels. The geographic dispersion of headquarters in Germany, the United States, Ireland, the United Kingdom, and elsewhere reflects diverse regulatory environments and reimbursement structures that influence product design, safety features, and after-market service. Across elastomeric pumps, electronic infusion pumps, and vascular access devices, the market emphasizes ease of use, portability, wireless connectivity, and integrated data capture to support adherence and remote monitoring. Regulatory compliance remains a core competency, with companies pursuing ISO, CE, and FDA clearances while maintaining robust post-market surveillance. As the home infusion economy expands—driven by chronic disease prevalence, aging populations, and hospital-at-home initiatives—these ten players will continue to compete on durability, safety, total cost of ownership, and customer support, shaping care delivery for millions of patients worldwide today.
Ten companies stand out in the Home Infusion Therapy Devices Market, reflecting the global scale and diversity of infusion technologies. B. Braun Melsungen AG, headquartered in Melsungen, Germany, is renowned for its Perfusor and Infusomat infusion pumps, elastomeric devices, and compatible disposables enabling safe, home administration of medications. Fresenius Kabi, based in Bad Homburg vor der Höhe, Germany, complements hospital programs with home-use infusion systems and supportive drug delivery solutions spanning elastomeric pumps, tubing sets, and infusion devices and services. ICU Medical, headquartered in San Clemente, USA, specializes in insulin and analgesia pumps and ancillary products, delivering portable, patient-centric devices for chronic therapy at home. Baxter International, headquartered in Deerfield, USA, leverages a portfolio of infusion systems, resins, and specialty drugs to support home infusion programs. Becton, Dickinson and Company, based in Franklin Lakes, USA, contributes precision infusion pumps, administration sets, and safety-engineered components used in ambulatory and home settings.
Medtronic plc, headquartered in Dublin, Ireland, extends home infusion therapy through its MiniMed insulin pumps, infusion sets, and digital diabetes management platform, enabling remote monitoring and data-informed therapy. Terumo Corporation, based in Tokyo, Japan, markets compact infusion pumps and compatible sets designed for home care, enabling seamless hospital-to-home transitions and safe outpatient administration. Nipro Corporation, headquartered in Osaka, Japan, supplies elastomeric pumps, infusion sets, and IV administration components distributed globally to support ambulatory therapies and home-based regimens. Smiths Medical, headquartered in London, United Kingdom, offers elastomeric and electronic infusion pumps, plus safety-enhanced administration sets used extensively in home infusion programs. AngioDynamics, headquartered in Latham, United States, emphasizes vascular access devices, catheters, and adjunct infusion therapies that support outpatient and home-based infusion pathways. Together, these ten firms shape the market's technological diversity, regulatory compliance, and patient-facing design, driving adoption of home-based chronic therapy and reducing hospital stays across emerging markets globally.
Together, these ten firms shape the competitive landscape of home infusion therapy by combining device ingenuity with manufacturing and distribution networks that reach clinics, home health agencies, and direct-to-patient channels. The geographic dispersion of headquarters in Germany, the United States, Ireland, the United Kingdom, and elsewhere reflects diverse regulatory environments and reimbursement structures that influence product design, safety features, and after-market service. Across elastomeric pumps, electronic infusion pumps, and vascular access devices, the market emphasizes ease of use, portability, wireless connectivity, and integrated data capture to support adherence and remote monitoring. Regulatory compliance remains a core competency, with companies pursuing ISO, CE, and FDA clearances while maintaining robust post-market surveillance. As the home infusion economy expands—driven by chronic disease prevalence, aging populations, and hospital-at-home initiatives—these ten players will continue to compete on durability, safety, total cost of ownership, and customer support, shaping care delivery for millions of patients worldwide today.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
